APAC Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	183 Pages	Data Bridge Market Research	May, 2022	DAABD17330399

Best Price Guarantee
Price	from $3,500
Length	183 Pages
Publisher	Data Bridge Market Research
Published Date	May, 2022
SKU	DAABD17330399

APAC Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Asia-Pacific psychedelic drugs market is projected to register a healthy CAGR of 11.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:
Asia-Pacific Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) Country (India, Australia, South Korea, Singapore, Malaysia and Rest of Asia-Pacific) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the Asia-Pacific psychedelic drugs market are:
• Due to growing clinical trials in the market
• Growing Acceptance Of Psychedelic Drugs For Treating Depression

Market Players

The key market players for Asia-Pacific psychedelic drugs market are listed below:
• Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.)
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Asia Pacific Psychedelic Drugs Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insight: 4.1 Pipeline Analysis; 4.2 Pestel Analysis; 4.3 Porter's Five Forces Model
5 Regulatory Framework: Asia Pacific Psychedelic Drugs Market: 5.1 Regulatory Scenario In The U.S.; 5.2 Regulatory Scenario In The U.K.; 5.3 Regulatory Scenario In India; 5.4 Regulatory Scenario In Uae; 5.5 Regulatory Scenario In Africa; 5.6 Regulatory Scenario In Brazil
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Acceptance Of Psychedelic Drugs To Treat Depression; 6.1.2 Increasing Prevalence Of Depression And Mental Disorders; 6.1.3 Rising Awareness Toward Mental Health; 6.1.4 Ongoing Clinical Trials; 6.1.5 Rise In Product Approvals; 6.2 Restraints; 6.2.1 Stringent Regulations For Psychedelic Drugs; 6.2.2 High Cost Of Psychedelic Drugs; 6.2.3 Patent Expiry Of Psychedelic Drugs; 6.3 Opportunities; 6.3.1 Increasing R&D Activities In Psychedelic Drugs; 6.3.2 Breakthrough Therapy Designation By Regulatory Authority; 6.3.3 Upcoming Rehabilitation Centers; 6.3.4 Availability Of Certified Healthcare Professionals; 6.4 Challenges; 6.4.1 Side Effects Associated With Psychedelic Drugs; 6.4.2 Rise In Illegal Alternatives; 6.4.3 Availability Of Other Treatment Options
7 Covid-19 Impact On The Asia Pacific Psychedelic Drugs Market: 7.1 Impact On Price; 7.2 Impact On Demand; 7.3 Impact On Supply Chain; 7.4 Strategic Decisions For Manufacturers; 7.5 Conclusion
8 Asia Pacific Psychedelic Drugs Market, By Type: 8.1 Overview; 8.2 Empathogens; 8.3 Dissociatives; 8.4 Others
9 Asia Pacific Psychedelic Drugs Market, By Source: 9.1 Overview; 9.2 Synthetic; 9.3 Natural
10 Asia Pacific Psychedelic Drugs Market, By Drugs: 10.1 Overview; 10.2 Gamma-hydroxybutyric Acid; 10.3 Ketamine; 10.4 Psilocybin; 10.5 Others
11 Asia Pacific Psychedelic Drugs Market, By Application: 11.1 Overview; 11.2 Narcolepsy; 11.3 Treatment Resistant Depression; 11.4 Major Depressive Disorder; 11.5 Opiate Addiction; 11.6 Post-traumatic Stress Disorder; 11.7 Others
12 Asia Pacific Psychedelic Drugs Market, By Route Of Administration: 12.1 Overview; 12.2 Oral; 12.3 Inhalation; 12.4 Injectable
13 Asia Pacific Psychedelic Drugs Market, By End User: 13.1 Overview; 13.2 Hospitals; 13.3 Specialty Clinics; 13.4 Homecare; 13.5 Others
14 Asia Pacific Psychedelic Drugs Market, By Distribution Channel: 14.1 Overview; 14.2 Hospitals Pharmacy; 14.3 Retail Pharmacy; 14.4 Online Pharmacy
15 Asia Pacific Psychedelic Drugs Market, By Region: 15.1 Asia-pacific; 15.1.1 India; 15.1.2 Australia; 15.1.3 South Korea; 15.1.4 Singapore; 15.1.5 Malaysia
16 Asia Pacific Psychedelic Drugs Market: Company Landscape: 16.1 Company Share Analysis: Asia Pacific
17 Swot Analysis
18 Company Profile: 18.1 Jazz Pharmaceuticals, Inc.; 18.1.1 Company Snapshot; 18.1.2 Revenue Analysis; 18.1.3 Company Share Analysis; 18.1.4 Product Portfolio; 18.1.5 Recent Developments; 18.2 Pfizer Inc.; 18.2.1 Company Snapshot; 18.2.2 Revenue Analysis; 18.2.3 Company Share Analysis; 18.2.4 Product Portfolio; 18.2.5 Recent Developments; 18.3 F. Hoffmann- La Roche Ltd; 18.3.1 Company Snapshot; 18.3.2 Revenue Analysis; 18.3.3 Company Share Analysis; 18.3.4 Product Portfolio; 18.3.5 Recent Development; 18.4 Janssen Asia Pacific Services, Llc (A Subsidiary Of Johnson & Johnson Services, Inc.); 18.4.1 Company Snapshot; 18.4.2 Company Share Analysis; 18.4.3 Product Portfolio; 18.4.4 Recent Development; 18.5 Avadel; 18.5.1 Company Snapshot; 18.5.2 Product Portfolio; 18.5.3 Recent Development; 18.6 Celon Pharma Sa; 18.6.1 Company Snapshot; 18.6.2 Product Portfolio; 18.6.3 Recent Development; 18.7 Compass; 18.7.1 Company Snapshot; 18.7.2 Product Portfolio; 18.7.3 Recent Developments; 18.8 Cybin Corp.; 18.8.1 Company Snapshot; 18.8.2 Product Portfolio; 18.8.3 Recent Developments; 18.9 Entheon Biomedical Corp; 18.9.1 Company Snapshot; 18.9.2 Product Portfolio; 18.9.3 Recent Development; 18.10 Gh Research; 18.10.1 Company Snapshot; 18.10.2 Product Portfolio; 18.10.3 Recent Development; 18.11 Hikma Pharmaceuticals Plc; 18.11.1 Company Snapshot; 18.11.2 Revenue Analysis; 18.11.3 Product Portfolio; 18.11.4 Recent Developments; 18.12 Nrx Pharmaceuticals, Inc.; 18.12.1 Company Snapshot; 18.12.2 Product Portfolio; 18.12.3 Recent Development; 18.13 Pharmather Holdings Ltd.; 18.13.1 Company Snapshot; 18.13.2 Product Portfolio; 18.13.3 Recent Development; 18.14 Verrian; 18.14.1 Company Snapshot; 18.14.2 Product Portfolio; 18.14.3 Recent Development; 18.15 Usonainstitute.Org; 18.15.1 Company Snapshot; 18.15.2 Product Portfolio; 18.15.3 Recent Development
19 Questionnaire
20 Related Reports
List Of Tables: Table 1 Asia Pacific Psychedelic Drugs Market, Pipeline Analysis; Table 2 Psychedelics Research Studies, In Europe; Table 3 Mental Illness In The U.S. Adults, In 2020; Table 4 Mental Disorders, In The U.S. Adults, In 2020; Table 5 Drug Development Pathway For Fda Approval Of New Medications; Table 6 The 1971 Un Convention On Psychotropic Substances; Table 7 Magic Mushrooms Prices For Researchers, In The U.S.; Table 8 Cost Of Psychedelic Drugs; Table 9 Psychedelic Drugs R&D Activities; Table 10 Asia Pacific Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 11 Asia Pacific Empathogens In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 12 Asia Pacific Dissociatives In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 13 Asia Pacific Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 14 Asia Pacific Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 15 Asia Pacific Synthetic In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 16 Asia Pacific Natural In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 17 Asia Pacific Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 18 Asia Pacific Gamma-hydroxybutyric Acid In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 19 Asia Pacific Ketamine In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 20 Asia Pacific Psilocybin In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 21 Asia Pacific Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 22 Asia Pacific Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 23 Asia Pacific Narcolepsy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 24 Asia Pacific Treatment Resistant Depression In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 25 Asia Pacific Major Depressive Disorder In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 26 Asia Pacific Opiate Addiction In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 27 Asia Pacific Post-traumatic Stress Disorder In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 28 Asia Pacific Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 29 Asia Pacific Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 30 Asia Pacific Oral In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 31 Asia Pacific Inhalation In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 32 Asia Pacific Injectable In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 33 Asia Pacific Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 34 Asia Pacific Hospitals In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 35 Asia Pacific Specialty Clinics In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 36 Asia Pacific Homecare In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 37 Asia Pacific Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 38 Asia Pacific Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 39 Asia Pacific Hospitals Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 40 Asia Pacific Retail Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 41 Asia Pacific Online Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 42 Asia-pacific Psychedelic Drugs Market, By Country, 2020-2029 (Usd Million); Table 43 Asia-pacific Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 44 Asia-pacific Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 45 Asia-pacific Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 46 Asia-pacific Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 47 Asia-pacific Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 48 Asia-pacific Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 49 Asia-pacific Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 50 India Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 51 India Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 52 India Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 53 India Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 54 India Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 55 India Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 56 India Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 57 Australia Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 58 Australia Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 59 Australia Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 60 Australia Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 61 Australia Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 62 Australia Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 63 Australia Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 64 South Korea Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 65 South Korea Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 66 South Korea Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 67 South Korea Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 68 South Korea Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 69 South Korea Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 70 South Korea Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 71 Singapore Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 72 Singapore Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 73 Singapore Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 74 Singapore Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 75 Singapore Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 76 Singapore Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 77 Singapore Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 78 Malaysia Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 79 Malaysia Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 80 Malaysia Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 81 Malaysia Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 82 Malaysia Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 83 Malaysia Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 84 Malaysia Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures: Figure 1 Asia Pacific Psychedelic Drugs Market: Segmentation; Figure 2 Asia Pacific Psychedelic Drugs Market : Data Triangulation; Figure 3 Asia Pacific Psychedelic Drugs Market: Droc Analysis; Figure 4 Asia Pacific Psychedelic Drugs Market: Asia Pacific Vs Regional Market Analysis; Figure 5 Asia Pacific Psychedelic Drugs Market: Company Research Analysis; Figure 6 Asia Pacific Psychedelic Drugs Market: Multivariate Modelling; Figure 7 Asia Pacific Psychedelic Drugs Market: Interview Demographics; Figure 8 Asia Pacific Psychedelic Drugs Market: Dbmr Market Position Grid; Figure 9 Asia Pacific Psychedelic Drugs Market: End User Coverage Grid; Figure 10 Asia Pacific Psychedelic Drugs Market: Vendor Share Analysis; Figure 11 Asia Pacific Psychedelic Drugs Market: Segmentation; Figure 12 North America Is Expected To Dominate The Asia Pacific Psychedelic Drugs Market Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029; Figure 13 Rising Awareness Towards Merantal Health Driving The Asia Pacific Psychedelic Drugs Market In The Forecast Period Of 2022 To 2029; Figure 14 Empathogens Segment Is Expected To Account For The Largest Share Of The Asia Pacific Psychedelic Drugs Market In 2022 & 2029; Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Asia Pacific Psychedelic Drugs Market; Figure 16 Mental Illness Among The U.S. Adults, In 2020, (In %), By Demographic Groups; Figure 17 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Demographic Groups; Figure 18 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Gender; Figure 19 Asia Pacific Psychedelic Drugs Market: By Type, 2021; Figure 20 Asia Pacific Psychedelic Drugs Market: By Type, 2022-2029 (Usd Million); Figure 21 Asia Pacific Psychedelic Drugs Market: By Type, Cagr (2022-2029); Figure 22 Asia Pacific Psychedelic Drugs Market: By Type, Lifeline Curve; Figure 23 Asia Pacific Psychedelic Drugs Market: By Source, 2021; Figure 24 Asia Pacific Psychedelic Drugs Market: By Source, 2022-2029 (Usd Million); Figure 25 Asia Pacific Psychedelic Drugs Market: By Source, Cagr (2022-2029); Figure 26 Asia Pacific Psychedelic Drugs Market: By Source, Lifeline Curve; Figure 27 Asia Pacific Psychedelic Drugs Market: By Drugs, 2021; Figure 28 Asia Pacific Psychedelic Drugs Market: By Drugs, 2022-2029 (Usd Million); Figure 29 Asia Pacific Psychedelic Drugs Market: By Drugs, Cagr (2022-2029); Figure 30 Asia Pacific Psychedelic Drugs Market: By Drugs, Lifeline Curve; Figure 31 Asia Pacific Psychedelic Drugs Market: By Application, 2021; Figure 32 Asia Pacific Psychedelic Drugs Market: By Application, 2022-2029 (Usd Million); Figure 33 Asia Pacific Psychedelic Drugs Market: By Application, Cagr (2022-2029); Figure 34 Asia Pacific Psychedelic Drugs Market: By Application, Lifeline Curve; Figure 35 Asia Pacific Psychedelic Drugs Market: By Route Of Administration, 2021; Figure 36 Asia Pacific Psychedelic Drugs Market: By Route Of Administration, 2022-2029 (Usd Million); Figure 37 Asia Pacific Psychedelic Drugs Market: By Route Of Administration, Cagr (2022-2029); Figure 38 Asia Pacific Psychedelic Drugs Market: By Route Of Administration, Lifeline Curve; Figure 39 Asia Pacific Psychedelic Drugs Market: By End User, 2021; Figure 40 Asia Pacific Psychedelic Drugs Market: By End User, 2022-2029 (Usd Million); Figure 41 Asia Pacific Psychedelic Drugs Market: By End User, Cagr (2022-2029); Figure 42 Asia Pacific Psychedelic Drugs Market: By End User, Lifeline Curve; Figure 43 Asia Pacific Psychedelic Drugs Market: By Distribution Channel, 2021; Figure 44 Asia Pacific Psychedelic Drugs Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 45 Asia Pacific Psychedelic Drugs Market: By Distribution Channel, Cagr (2022-2029); Figure 46 Asia Pacific Psychedelic Drugs Market: By Distribution Channel, Lifeline Curve; Figure 47 Asia-pacific Psychedelic Drugs Market: Snapshot (2021); Figure 48 Asia-pacific Psychedelic Drugs Market: By Country (2021); Figure 49 Asia-pacific Psychedelic Drugs Market: By Country (2022 & 2029); Figure 50 Asia-pacific Psychedelic Drugs Market: By Country (2021 & 2029); Figure 51 Asia-pacific Psychedelic Drugs Market: By Type (2022-2029); Figure 52 Asia Pacific Psychedelic Drugs Market: Company Share 2021 (%)